CN111529618A - Externally applied traditional Chinese medicine composition for treating facial paralysis - Google Patents

Externally applied traditional Chinese medicine composition for treating facial paralysis Download PDF

Info

Publication number
CN111529618A
CN111529618A CN202010469061.8A CN202010469061A CN111529618A CN 111529618 A CN111529618 A CN 111529618A CN 202010469061 A CN202010469061 A CN 202010469061A CN 111529618 A CN111529618 A CN 111529618A
Authority
CN
China
Prior art keywords
parts
traditional chinese
chinese medicine
facial paralysis
green leaves
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010469061.8A
Other languages
Chinese (zh)
Inventor
郑汉吉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zheng Guanglong
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202010469061.8A priority Critical patent/CN111529618A/en
Publication of CN111529618A publication Critical patent/CN111529618A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/24Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/57Magnoliaceae (Magnolia family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/79Schisandraceae (Schisandra family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962Allium, e.g. garden onion, leek, garlic or chives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses an external application traditional Chinese medicine composition for treating facial paralysis, which comprises the following raw materials: green leaves or roots of fructus Capsici, green leaves or rhizome of fructus Schisandrae chinensis, Glycyrrhrizae radix, loess, and Bulbus Allii. The topical Chinese medicinal composition is applied to the arm opposite to facial paralysis direction. The traditional Chinese medicine composition has the advantages of reasonable compatibility of medicines, complementary synergy, dialectical treatment, quick response, good curative effect and no toxic or side effect.

Description

Externally applied traditional Chinese medicine composition for treating facial paralysis
Technical Field
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to an external application traditional Chinese medicine composition for treating facial paralysis.
Background
Facial paralysis, also known as facial neuritis, commonly known as facial paralysis and facial paralysis, is a common disease mainly characterized by motor dysfunction of facial expression muscles, and is generally characterized by facial distortion. It is a common disease. It is not limited by age and sex, and the patient's face often can't be accomplished even the most basic actions such as raising the eyebrow, closing the eye, etc. The long-term wind cold on the face can cause the blockage of the meridians and collaterals of the face and the blockage of qi and blood, and the contraction of blood vessels of the face easily occurs due to the blood circulation disorder, so that the ischemia and edema of facial nerves can be caused. Some people often blow suddenly towards an air opening of an air conditioner or a fan after exercise or feel hot in summer, and suddenly attacked cold air invades facial microcirculation, stimulates facial nerves and blood vessels to contract, influences blood supply disorder and further causes facial paralysis.
Aiming at the treatment, western medicine usually applies some nutritional nerve medicines, but the effect is not good, and the traditional Chinese medicine is generally combined treatment of traditional Chinese medicine and acupuncture. The treatment course of the traditional Chinese medicine preparation needs to be according to the constitution of the patient, so that some people can recover quickly, and some people can recover slowly; the phenomena of long treatment process, high cost, serious influence on normal work and life and the like generally exist.
Disclosure of Invention
Aiming at the defects in the prior art, the invention provides an external application traditional Chinese medicine composition for treating facial paralysis.
In order to achieve the purpose, the technical scheme of the invention is as follows:
an externally applied traditional Chinese medicine composition for treating facial paralysis comprises the following raw materials:
green leaves or roots of fructus Capsici, green leaves or rhizome of fructus Schisandrae chinensis, Glycyrrhrizae radix, loess, and Bulbus Allii.
Further, the externally applied traditional Chinese medicine composition for treating facial paralysis comprises the following raw materials in parts by weight:
20-55 parts of wild pepper green leaves or wild pepper roots, 10-30 parts of schisandra green leaves or schisandra rhizomes, 5-25 parts of liquorice, 5-15 parts of loess and 2-10 parts of garlic.
Further, the externally applied traditional Chinese medicine composition for treating facial paralysis comprises the following raw materials in parts by weight:
49 parts of wild pepper green leaves or wild pepper roots, 20 parts of schisandra green leaves or schisandra rhizomes, 15 parts of liquorice, 10 parts of loess and 6 parts of garlic.
Furthermore, the wild pepper is used in the summer and autumn of the green leaves of the wild pepper, and is used in the autumn and winter of the root of the wild pepper.
Furthermore, the rhizome of Schisandra chinensis is used in winter, and the green leaves of Schisandra chinensis are used in the rest three seasons.
Has the advantages that: the traditional Chinese medicine composition has the advantages of reasonable compatibility of medicines, complementary synergy, dialectical treatment, quick response, good curative effect and no toxic or side effect.
Detailed Description
The invention is illustrated below with reference to specific examples. It will be understood by those skilled in the art that these examples are for illustrative purposes only and are not intended to limit the scope of the present invention in any way.
Example 1
An external application traditional Chinese medicine composition for treating facial paralysis comprises the following raw materials in parts by weight: 49 parts of wild pepper green leaves or wild pepper roots, 20 parts of schisandra green leaves or schisandra rhizomes, 15 parts of liquorice, 10 parts of loess and 6 parts of garlic.
Example 2
An external application traditional Chinese medicine composition for treating facial paralysis comprises the following raw materials in parts by weight: 55 parts of wild pepper green leaves or wild pepper roots, 10 parts of schisandra green leaves or schisandra rhizomes, 10 parts of liquorice, 15 parts of loess and 10 parts of garlic.
Example 3
An external application traditional Chinese medicine composition for treating facial paralysis comprises the following raw materials in parts by weight: 20 parts of wild pepper green leaves or wild pepper roots, 30 parts of schisandra green leaves or schisandra rhizomes, 25 parts of liquorice, 15 parts of loess and 10 parts of garlic.
Clinical data
The clinical observation of the traditional Chinese medicine for treating facial paralysis:
1.1 general data
Clinical comparative medication observation is carried out on 96 facial paralysis patients who visit the clinic, wherein 50 men and 46 women have the shortest disease course of 3 days and the longest disease course of 1 year. All patients were randomly divided into 48 treatment groups and 48 western medicine groups.
1.2 methods of treatment
Treatment groups: example 1 is applied to the arm on the opposite side of the facial paralysis direction, the medicine is taken out 18 to 24 hours after the medicine is applied, the blister formed at the medicine application position is punctured by a non-metal tool, and other skin positions where the effluent water can not be dyed are absorbed by medical cotton; the healing period is 5-15 days; during treatment, meat, eggs and beans (bean curd, soybean milk and the like) wine dairy products (cow milk, goat milk and the like) are prohibited.
And (4) western medicine treatment groups: prednisone is orally administered in the acute phase for 7 consecutive days, and gradually decreased within 7 days thereafter. If there is definite evidence of viral infection, antiviral drugs can be used simultaneously; vitamins B1 and B12 can be administered for the whole course of treatment. The treatment lasts for 15 days.
1.3 criteria for efficacy assessment
And (3) healing: all areas of the face were normal. Including bilateral forehead lines and nasolabial sulcus, normal eyebrow wrinkling and eye closing, no air leakage at mouth corners during gill bulging, no food residue retention between teeth and cheeks during eating, no facial distortion during talking, and normal facial expression.
The effect is shown: careful observation can reveal slight functional weakening, possibly with slight associated movement; the face is symmetrical when the face is static, the tension is normal, the upper jaw moves moderately, the eyes can be completely closed when exerting force, and the mouth is not symmetrical in lightness.
The method has the following advantages: the function is obviously weakened, no damage and asymmetry exist on one side and two sides, and less serious joint movement, contracture and/or hemifacial spasm can be observed; when the face is still, the tension is normal, the upper jaw moves weakly, the eye can be completely closed when the eye exerts force, and the mouth is obviously asymmetric.
And (4) invalidation: after 3 treatment courses, the face is asymmetric when the face is static, the upper jaw does not move, the eyes cannot be completely closed, and the mouth only moves slightly.
1.4 treatment results, see Table 1
TABLE 1 therapeutic data for treatment of facial paralysis by two groups of treatment methods
Group of Number of examples Cure (%) Significant effect (%) Effective (%) Null (%) Total effective rate (%)
Treatment group 48 32(66.6) 8(16.6) 5(10.4) 3(6.25) 45(93.75)
Western medicine group 48 20(41.6) 11(22.9) 7(14.5) 8(16.7) 40(83.3)
As can be seen from Table 1, the cure rate of the treatment group of the invention is as high as 66, 6%, which is higher than that of the western medicine group. The total effective rate is 93.75 percent and is higher than that of western medicine groups. Compared with the prior art, the traditional Chinese medicine for treating facial paralysis has the advantages of high cure rate, short treatment course and the like.
II, typical cases:
1. plum, male, 28 years old, camping, catching cold, facial distortion the next day, dizziness and hypodynamia, incomplete eye closure, asymmetric tympanitis, thin tongue coating and thin pulse; after the traditional Chinese medicine is externally applied for 1 course, the symptoms of facial muscles are improved, and after the traditional Chinese medicine is externally applied for 3 courses, all symptoms disappear and the patients are cured.
2. Somebody in the sun, male, age 54, suffered from facial paralysis for 3 months, facial distortion, inability to drum the gills, thin and white tongue coating, and floating pulse due to overwork at night and wind-cold invasion. After the traditional Chinese medicine is externally applied for 1 course, the symptoms of facial muscles are improved, and after the traditional Chinese medicine is externally applied for 3 courses, all symptoms disappear and the patients are cured.
3. If a certain woman is in 37 years old, the patient suffers from facial paralysis caused by cold wind 7 days before suffering from the cold wind, the muscles of the right face are stiff, the mouth and eyes are crooked, and the facial paralysis is confirmed after examination. After the traditional Chinese medicine is externally applied for 1 course, the symptoms of facial muscles are improved, and after the traditional Chinese medicine is externally applied for 3 courses, all symptoms disappear and the patients are cured.

Claims (5)

1. An externally applied traditional Chinese medicine composition for treating facial paralysis is characterized by comprising the following raw materials:
green leaves or roots of fructus Capsici, green leaves or rhizome of fructus Schisandrae chinensis, Glycyrrhrizae radix, loess, and Bulbus Allii.
2. The externally applied traditional Chinese medicine composition for treating facial paralysis as claimed in claim 1, which comprises the following raw materials by weight:
20-55 parts of wild pepper green leaves or wild pepper roots, 10-30 parts of schisandra green leaves or schisandra rhizomes, 5-25 parts of liquorice, 5-15 parts of loess and 2-10 parts of garlic.
3. The externally applied traditional Chinese medicine composition for treating facial paralysis as claimed in claim 1, which comprises the following raw materials by weight:
49 parts of wild pepper green leaves or wild pepper roots, 20 parts of schisandra green leaves or schisandra rhizomes, 15 parts of liquorice, 10 parts of loess and 6 parts of garlic.
4. The topical Chinese medicinal composition for treating facial paralysis of any one of claims 1-3, wherein the green leaves of fructus Capsici are used in summer and autumn, and the roots of fructus Capsici are used in autumn and winter.
5. The topical Chinese medicinal composition for treating facial paralysis as claimed in any one of claims 1-3, wherein the rhizome of fructus Schisandrae chinensis is used in winter, and the green leaves of fructus Schisandrae chinensis are used in the other three seasons.
CN202010469061.8A 2020-05-28 2020-05-28 Externally applied traditional Chinese medicine composition for treating facial paralysis Pending CN111529618A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010469061.8A CN111529618A (en) 2020-05-28 2020-05-28 Externally applied traditional Chinese medicine composition for treating facial paralysis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010469061.8A CN111529618A (en) 2020-05-28 2020-05-28 Externally applied traditional Chinese medicine composition for treating facial paralysis

Publications (1)

Publication Number Publication Date
CN111529618A true CN111529618A (en) 2020-08-14

Family

ID=71969085

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010469061.8A Pending CN111529618A (en) 2020-05-28 2020-05-28 Externally applied traditional Chinese medicine composition for treating facial paralysis

Country Status (1)

Country Link
CN (1) CN111529618A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102973768A (en) * 2012-12-25 2013-03-20 陈金宗 Qianzheng paste for treating acute and chronic facial paralysis
CN103223006A (en) * 2013-05-07 2013-07-31 牛贵君 Traditional Chinese medical composition for treating facial paralysis
CN104189861A (en) * 2014-09-24 2014-12-10 唐国萍 Traditional Chinese medicine for treating facial paralysis

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102973768A (en) * 2012-12-25 2013-03-20 陈金宗 Qianzheng paste for treating acute and chronic facial paralysis
CN103223006A (en) * 2013-05-07 2013-07-31 牛贵君 Traditional Chinese medical composition for treating facial paralysis
CN104189861A (en) * 2014-09-24 2014-12-10 唐国萍 Traditional Chinese medicine for treating facial paralysis

Similar Documents

Publication Publication Date Title
CN104906220B (en) A kind of Chinese medicine for treating herpes zoster and herpes simplex keratitis
CN111529618A (en) Externally applied traditional Chinese medicine composition for treating facial paralysis
CN1160091C (en) Medicine for treating ophthalmopathy
CN104367832A (en) Compound dendrobe eye drops for treating xerophthalmia and preparation method thereof
CN104027719B (en) Traditional Chinese medicine compound composition of hypersplenia liver-depression and spleen-insufficiency type disease caused with treatment infectious endocarditis and preparation method thereof
CN110302357A (en) A kind of external application eyesight-improving health care function Chinese medicine composition and preparation method thereof
CN104815151A (en) Traditional Chinese medicine for treating warm-dryness lung injury type cough
CN105726983A (en) Compound dendrobium eye drops for treating xerophthalmia and preparation method thereof
CN104997945A (en) Traditional Chinese medicine for treating urocystitis
CN104524252A (en) Traditional Chinese medicine preparation for treating demented symptom
CN108403764A (en) A kind of external preparation and preparation method for treating Facial Recurrent Dermatitis
CN103893669B (en) A kind of Chinese medicine composition for the treatment of tinea pedis and preparation method thereof and application
CN114377054B (en) Use of cyclocarya paliurus leaves or extracts thereof in preparation of drugs or cosmetics for preventing and/or treating acne
CN116920023B (en) External traditional Chinese medicine composition for treating diabetic peripheral neuropathy and application thereof
CN110787237B (en) Traditional Chinese medicine composition for effectively treating gastrocnemius spasm and preparation method and application thereof
CN105232902A (en) Medicine combination treating venomous snake bite
CN110170020B (en) Traditional Chinese medicine mask for beautifying and removing freckles
CN105663953A (en) Traditional Chinese medicine powder for treating stroke and facial paralysis
CN106214906B (en) Medicinal composition for treating bromhidrosis and preparation method thereof
CN105663959A (en) Traditional Chinese medicine preparation for nursing patient suffering from toothache and preparation method
CN104958653A (en) Traditional Chinese medicine composition for treating tuberculosis
CN115025182A (en) Traditional Chinese medicine preparation for treating respiratory virus infection
CN105727132A (en) Traditional Chinese medicine eye drops for treating eye inflammation and preparation method thereof
CN107837337A (en) It is a kind of to be used to treat ointment medicine of chloasma and preparation method thereof
CN103751553B (en) One treats the parotitic Chinese medicine of anemopyretic

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right

Effective date of registration: 20211025

Address after: 132500 Wujiazi village, Xinzhan Town, Jiaohe City, Jilin Province

Applicant after: Zheng Guanglong

Address before: 132500 Wujiazi village, Xinzhan Town, Jiaohe City, Jilin Province

Applicant before: Zheng Hanji

TA01 Transfer of patent application right
RJ01 Rejection of invention patent application after publication

Application publication date: 20200814

RJ01 Rejection of invention patent application after publication